文献速递鼻科

单一与多重致敏患者舌下免疫治疗后的免疫学改变

Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy.
PubMed 文献 · Laryngoscope · 2018-12-13

这项回顾性队列研究比较了单一致敏与多重致敏过敏性鼻炎患者接受尘螨提取物舌下免疫治疗2年后的免疫学改变和疗效。单一组屋尘螨特异性IgG4升高显著高于多重组(P=.020和P=.005),两组鼻症状总分均显著改善(均P<.001),但组间改善幅度无显著差异(P=.374)。

要点

  • 单一组屋尘螨特异性IgG4升高显著高于多重组(P=.020和P=.005)。
  • 两组鼻症状总分在舌下免疫治疗后均显著改善(均P<.001)。
  • 两组鼻症状总分较基线变化幅度无显著差异(P=.374)。

核心结论

  • 单一与多重致敏患者舌下免疫治疗后免疫学改变不同,但多重致敏患者接受单一过敏原舌下免疫治疗的鼻症状改善与单一组相当。

研究设计与样本

  • 回顾性队列研究,纳入前瞻性舌下免疫治疗队列研究中对屋尘螨致敏并接受舌下免疫治疗至少2年的过敏性鼻炎患者,基线及治疗后进行血清学检测。
  • 根据鼻症状总分较基线下降是否达50%分为有效组和效果欠佳组。

主要发现

  • 单一致敏组屋尘螨特异性IgG4升高显著高于多重致敏组(P=.020和P=.005)。
  • 单一组和多重组鼻症状总分在舌下免疫治疗后均显著改善(均P<.001)。
  • 两组鼻症状总分较基线变化差异无统计学意义(P=.374)。

临床怎么用

  • 作者认为多重致敏患者接受单一过敏原舌下免疫治疗可获得与单一致敏患者相当的临床症状改善,尽管免疫学改变不同。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: To compare immunologic modification and treatment outcomes after 2 years of sublingual immunotherapy (SLIT) with house dust mite extracts (HDM) between monosensitized and polysensitized patients with allergic rhinitis. STUDY DESIGN: Retrospective cohort study. METHODS: Among the patients who were prospectively enrolled in the SLIT cohort study, patients with allergic rhinitis who were sensitized to HDM and treated with SLIT for at least 2 years were studied. All participants underwent serologic tests at baseline and after SLIT to evaluate changes in immunologic parameters. The total nasal symptom score (TNSS) was measured before and after SLIT, and effective and less effective responder groups were categorized depending on whether patients had a TNSS reduction of 50%, as compared with baseline. RESULTS: The increase in Dermatophagoides pteronyssinus and Dermatophagoides farinae specific immunoglobulin G4 levels was significantly higher in monosensitized patients than in polysensitized patients (P = .020 and P = .005, respectively). The TNSS significantly improved after SLIT in both the monosensitized and polysensitized groups (P < .001 in both groups). However, the difference in the changes in TNSS from baseline was not significant between the two groups (P = .374). CONCLUSIONS: This study demonstrated different immunologic modifications after SLIT between monosensitized and polysensitized patients. However, patients in the polysensitized group who were treated with single-allergen SLIT experienced clinical improvement in TNSS that was comparable with that in the monosensitized group despite demonstrating different immunologic changes. LEVEL OF EVIDENCE: 2b Laryngoscope, 129:E170-E177, 2019.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kim JY, Han DH, Won TB, et al. Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy. Laryngoscope. 2018. PMID: 30548878. doi:10.1002/lary.27721

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。